Can I take Replenza with my GLP-1 medication
Speak to your healthcare provider if you're on long-term antibiotics, as they might recommend a different approach
Disease modifying agents capable of controlling obesity with meaningful metabolic improvement have reshaped expectations for both clinicians and patients ( Nausea and vomiting remain among the most frequent and disruptive adverse effects across Glucagon-like peptide (GLP-1)-based therapies ( In this opinion article, we examine the mechanisms underlying nausea and vomiting in semaglutide, CagriSema, survodutide, tirzepatide, retatrutide, and orforglipron and situate them within obesity clinical practice ( We also propose practical strategies to mitigate gastrointestinal intolerance
PMID: 90 LscherAVionnetNAmiguetMChartoumpekisDMantziariSFrantzJet al
Glutamine is the most abundant amino acid in your whole body, and is used in more bodily functions and processes than any other amino acid
KFF Health Tracking Poll May 2024: The Publics Use and Views of GLP-1 Drugs Findings Key Findings The latest KFF Health Tracking Poll finds that about one in eight adults (12%) say they have ever taken a GLP-1 agonist an increasingly popular class of prescription drugs used for weight loss and to treat diabetes or prevent heart attacks or strokes for adults with heart disease including 6% who say they are currently taking such a drug